PKI Stock Recent News
PKI LATEST HEADLINES
Partnership will expand reach of best-in-class PKI and certificate solutions throughout North America Partnership will expand reach of best-in-class PKI and certificate solutions throughout North America
CALGARY, AB , Aug. 12, 2024 /PRNewswire/ - Parkland Corporation ("Parkland", "we", the "Company", or "our") (TSX: PKI) announced today that it has priced its previously announced private offering of US$500 million of senior unsecured notes due 2032 at an issue price of par. The notes will pay a fixed rate of interest of 6.625% per annum.
CALGARY, AB , Aug. 12, 2024 /PRNewswire/ - Parkland Corporation ("Parkland", "we", the "Company", or "our") (TSX: PKI) announced today that, subject to market and other conditions, it plans to commence a private offering of US$500 million aggregate principal amount of senior unsecured notes due 2032. Parkland intends to use the net proceeds of the offering for the repayment of a portion of the outstanding drawings under its credit facilities.
PerkinElmer (PKI) came out with quarterly earnings of $1.01 per share, beating the Zacks Consensus Estimate of $0.99 per share. This compares to earnings of $2.41 per share a year ago.
Revvity (PKI) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
Revvity's (PKI) first-quarter results are likely to reflect weak performance at the Diagnostics segment, partially offset by strong demand for Life Sciences and Diagnostics franchise.
PerkinElmer (PKI) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.
PerkinElmer (PKI) completes separation of its businesses into two entities ??? the AES business, and the Life Sciences and Diagnostics business.
PerkinElmer's (PKI) latest launch is expected to provide increased assay flexibility to researchers.
PerkinElmer's (PKI) fourth-quarter results benefit from the solid performance of the Discover & Analytics Solutions business, more than offset by lower COVID-related sales.